Skip to main content
. 2013 Mar 27;8(3):e59630. doi: 10.1371/journal.pone.0059630

Figure 3. Blood cell numbers in inducible Sgpl1-deficient mice.

Figure 3

Mice were treated on 5 consecutive days with 40 mg/kg tamoxifen p.o. A, B, Two weeks after tamoxifen treatment of Sgpl1Flox/Flox Cre+/− mice (open bars) and of Sgpl1Flox/Flox Cre−/− controls (closed bars) (n = 5/group), differential blood cell counts were determined (A) and FACS analysis of lymphocyte subsets was performed (B). C, Time course of blood T cell number reduction in induced Sgpl1Flox/Flox Cre+/− mice. (n = 5/group). Blood samples were analysed at the indicated time points by FACS with staining for CD3/CD4 (closed bars) and CD3/CD8-double positive T cells (open bars).